Anti-microbial Packaging Materials
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Antiemetic Drugs Market Research Report 2023
1 Antiemetic Drugs Market Overview
1.1 Product Overview and Scope of Antiemetic Drugs
1.2 Antiemetic Drugs Segment by Type
1.2.1 Global Antiemetic Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Antiemetic Drugs Segment by Application
1.3.1 Global Antiemetic Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antiemetic Drugs Revenue 2017-2028
1.4.2 Global Antiemetic Drugs Sales 2017-2028
1.4.3 Antiemetic Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antiemetic Drugs Market Competition by Manufacturers
2.1 Global Antiemetic Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antiemetic Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antiemetic Drugs Manufacturing Sites, Area Served, Product Type
2.5 Antiemetic Drugs Market Competitive Situation and Trends
2.5.1 Antiemetic Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antiemetic Drugs Players Market Share by Revenue
2.5.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiemetic Drugs Retrospective Market Scenario by Region
3.1 Global Antiemetic Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antiemetic Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antiemetic Drugs Market Facts & Figures by Country
3.3.1 North America Antiemetic Drugs Sales by Country
3.3.2 North America Antiemetic Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antiemetic Drugs Market Facts & Figures by Country
3.4.1 Europe Antiemetic Drugs Sales by Country
3.4.2 Europe Antiemetic Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antiemetic Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Antiemetic Drugs Sales by Region
3.5.2 Asia Pacific Antiemetic Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antiemetic Drugs Market Facts & Figures by Country
3.6.1 Latin America Antiemetic Drugs Sales by Country
3.6.2 Latin America Antiemetic Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Antiemetic Drugs Sales by Country
3.7.2 Middle East and Africa Antiemetic Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antiemetic Drugs Historic Market Analysis by Type
4.1 Global Antiemetic Drugs Sales Market Share by Type (2017-2022)
4.2 Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Antiemetic Drugs Price by Type (2017-2022)
5 Global Antiemetic Drugs Historic Market Analysis by Application
5.1 Global Antiemetic Drugs Sales Market Share by Application (2017-2022)
5.2 Global Antiemetic Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Antiemetic Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Johnson & Johnson Antiemetic Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Antiemetic Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Antiemetic Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Abbott Antiemetic Drugs Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cipla Antiemetic Drugs Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Eisai
6.8.1 Eisai Corporation Information
6.8.2 Eisai Description and Business Overview
6.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Eisai Antiemetic Drugs Product Portfolio
6.8.5 Eisai Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eli Lilly Antiemetic Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Glenmark Antiemetic Drugs Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Helsinn Healthcare
6.11.1 Helsinn Healthcare Corporation Information
6.11.2 Helsinn Healthcare Antiemetic Drugs Description and Business Overview
6.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio
6.11.5 Helsinn Healthcare Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Corporation Information
6.12.2 Heron Therapeutics Antiemetic Drugs Description and Business Overview
6.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Heron Therapeutics Antiemetic Drugs Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 IPCA Laboratories
6.13.1 IPCA Laboratories Corporation Information
6.13.2 IPCA Laboratories Antiemetic Drugs Description and Business Overview
6.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 IPCA Laboratories Antiemetic Drugs Product Portfolio
6.13.5 IPCA Laboratories Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Corporation Information
6.14.2 Lupin Antiemetic Drugs Description and Business Overview
6.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Lupin Antiemetic Drugs Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Antiemetic Drugs Description and Business Overview
6.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Merck Antiemetic Drugs Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Antiemetic Drugs Description and Business Overview
6.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Novartis Antiemetic Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 RedHill
6.17.1 RedHill Corporation Information
6.17.2 RedHill Antiemetic Drugs Description and Business Overview
6.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 RedHill Antiemetic Drugs Product Portfolio
6.17.5 RedHill Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Corporation Information
6.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Takeda Pharmaceutical
6.19.1 Takeda Pharmaceutical Corporation Information
6.19.2 Takeda Pharmaceutical Antiemetic Drugs Description and Business Overview
6.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
6.19.5 Takeda Pharmaceutical Recent Developments/Updates
7 Antiemetic Drugs Manufacturing Cost Analysis
7.1 Antiemetic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antiemetic Drugs
7.4 Antiemetic Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antiemetic Drugs Distributors List
8.3 Antiemetic Drugs Customers
9 Antiemetic Drugs Market Dynamics
9.1 Antiemetic Drugs Industry Trends
9.2 Antiemetic Drugs Market Drivers
9.3 Antiemetic Drugs Market Challenges
9.4 Antiemetic Drugs Market Restraints
10 Global Market Forecast
10.1 Antiemetic Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antiemetic Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antiemetic Drugs by Type (2023-2028)
10.2 Antiemetic Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antiemetic Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antiemetic Drugs by Application (2023-2028)
10.3 Antiemetic Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antiemetic Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antiemetic Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antiemetic Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antiemetic Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antiemetic Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antiemetic Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antiemetic Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antiemetic Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antiemetic Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antiemetic Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antiemetic Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antiemetic Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Antiemetic Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antiemetic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiemetic Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Antiemetic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antiemetic Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antiemetic Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antiemetic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antiemetic Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antiemetic Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antiemetic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antiemetic Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Antiemetic Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Antiemetic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Antiemetic Drugs Revenue Share by Type (2017-2022)
Table 43. Global Antiemetic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Antiemetic Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Antiemetic Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Antiemetic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antiemetic Drugs Revenue Share by Application (2017-2022)
Table 48. Global Antiemetic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. GlaxoSmithKline Corporation Information
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Antiemetic Drugs Product
Table 53. GlaxoSmithKline Recent Developments/Updates
Table 54. Johnson & Johnson Corporation Information
Table 55. Johnson & Johnson Description and Business Overview
Table 56. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Johnson & Johnson Antiemetic Drugs Product
Table 58. Johnson & Johnson Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Antiemetic Drugs Product
Table 63. Pfizer Recent Developments/Updates
Table 64. Sanofi Corporation Information
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi Antiemetic Drugs Product
Table 68. Sanofi Recent Developments/Updates
Table 69. Abbott Corporation Information
Table 70. Abbott Description and Business Overview
Table 71. Abbott Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Abbott Antiemetic Drugs Product
Table 73. Abbott Recent Developments/Updates
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Description and Business Overview
Table 76. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Bristol-Myers Squibb Antiemetic Drugs Product
Table 78. Bristol-Myers Squibb Recent Developments/Updates
Table 79. Cipla Corporation Information
Table 80. Cipla Description and Business Overview
Table 81. Cipla Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Cipla Antiemetic Drugs Product
Table 83. Cipla Recent Developments/Updates
Table 84. Eisai Corporation Information
Table 85. Eisai Description and Business Overview
Table 86. Eisai Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Eisai Antiemetic Drugs Product
Table 88. Eisai Recent Developments/Updates
Table 89. Eli Lilly Corporation Information
Table 90. Eli Lilly Description and Business Overview
Table 91. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Eli Lilly Antiemetic Drugs Product
Table 93. Eli Lilly Recent Developments/Updates
Table 94. Glenmark Corporation Information
Table 95. Glenmark Description and Business Overview
Table 96. Glenmark Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Glenmark Antiemetic Drugs Product
Table 98. Glenmark Recent Developments/Updates
Table 99. Helsinn Healthcare Corporation Information
Table 100. Helsinn Healthcare Description and Business Overview
Table 101. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Helsinn Healthcare Antiemetic Drugs Product
Table 103. Helsinn Healthcare Recent Developments/Updates
Table 104. Heron Therapeutics Corporation Information
Table 105. Heron Therapeutics Description and Business Overview
Table 106. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Heron Therapeutics Antiemetic Drugs Product
Table 108. Heron Therapeutics Recent Developments/Updates
Table 109. IPCA Laboratories Corporation Information
Table 110. IPCA Laboratories Description and Business Overview
Table 111. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. IPCA Laboratories Antiemetic Drugs Product
Table 113. IPCA Laboratories Recent Developments/Updates
Table 114. Lupin Corporation Information
Table 115. Lupin Description and Business Overview
Table 116. Lupin Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Lupin Antiemetic Drugs Product
Table 118. Lupin Recent Developments/Updates
Table 119. Merck Corporation Information
Table 120. Merck Description and Business Overview
Table 121. Merck Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Merck Antiemetic Drugs Product
Table 123. Merck Recent Developments/Updates
Table 124. Novartis Corporation Information
Table 125. Novartis Description and Business Overview
Table 126. Novartis Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Novartis Antiemetic Drugs Product
Table 128. Novartis Recent Developments/Updates
Table 129. RedHill Corporation Information
Table 130. RedHill Description and Business Overview
Table 131. RedHill Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. RedHill Antiemetic Drugs Product
Table 133. RedHill Recent Developments/Updates
Table 134. Sun Pharmaceutical Industries Corporation Information
Table 135. Sun Pharmaceutical Industries Description and Business Overview
Table 136. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Sun Pharmaceutical Industries Antiemetic Drugs Product
Table 138. Sun Pharmaceutical Industries Recent Developments/Updates
Table 139. Takeda Pharmaceutical Corporation Information
Table 140. Takeda Pharmaceutical Description and Business Overview
Table 141. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Takeda Pharmaceutical Antiemetic Drugs Product
Table 143. Takeda Pharmaceutical Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Antiemetic Drugs Distributors List
Table 147. Antiemetic Drugs Customers List
Table 148. Antiemetic Drugs Market Trends
Table 149. Antiemetic Drugs Market Drivers
Table 150. Antiemetic Drugs Market Challenges
Table 151. Antiemetic Drugs Market Restraints
Table 152. Global Antiemetic Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global Antiemetic Drugs Sales Market Share Forecast by Type (2023-2028)
Table 154. Global Antiemetic Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global Antiemetic Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global Antiemetic Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global Antiemetic Drugs Sales Market Share Forecast by Application (2023-2028)
Table 158. Global Antiemetic Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global Antiemetic Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global Antiemetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global Antiemetic Drugs Sales Market Share Forecast by Region (2023-2028)
Table 162. Global Antiemetic Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global Antiemetic Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antiemetic Drugs
Figure 2. Global Antiemetic Drugs Market Share by Type in 2021 & 2028
Figure 3. Dopamine Antagonist Product Picture
Figure 4. 5-HT-3 Receptor Antagonist Product Picture
Figure 5. NK1 Receptor Antagonist Product Picture
Figure 6. Cannabinoid Receptor Antagonist Product Picture
Figure 7. Global Antiemetic Drugs Market Share by Application in 2021 & 2028
Figure 8. Chemotherapy
Figure 9. Gastroenteritis
Figure 10. Surgery
Figure 11. Global Antiemetic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antiemetic Drugs Market Size (2017-2028) & (US$ Million)
Figure 13. Global Antiemetic Drugs Sales (2017-2028) & (K Units)
Figure 14. Antiemetic Drugs Sales Share by Manufacturers in 2021
Figure 15. Global Antiemetic Drugs Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Antiemetic Drugs Players: Market Share by Revenue in 2021
Figure 17. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Antiemetic Drugs Sales Market Share by Region in 2021
Figure 20. Global Antiemetic Drugs Revenue Market Share by Region (2017-2022)
Figure 21. Global Antiemetic Drugs Revenue Market Share by Region in 2021
Figure 22. U.S. Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Antiemetic Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Antiemetic Drugs by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Antiemetic Drugs
Figure 48. Manufacturing Process Analysis of Antiemetic Drugs
Figure 49. Antiemetic Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Johnson & Johnson Pfizer Sanofi Abbott Bristol-Myers Squibb Cipla Eisai Eli Lilly Glenmark Helsinn Healthcare Heron Therapeutics IPCA Laboratories Lupin Merck Novartis RedHill Sun Pharmaceutical Industries Takeda Pharmaceutical